Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nichols Institute

This article was originally published in The Gray Sheet

Executive Summary

Chairman Albert Nichols, MD, and "certain other stockholders" replace three of the seven directors of the company. The new directors are Rock Hankin, a principal in the management consulting firm Hankin & Co.; George Bragg, former vice chairman of Western Digital; and Fredric Roberts, president of F.M. Roberts & Co., an investment banking firm. The trio replace Rosabeth Kanter, PhD, John Potts, Jr., MD, and James Riddell, PhD. Nichols will also seek the replacement of directors Norman Achen and Earl Wright. The other remaining board members are Nichols and Paul Bellamy, chief financial officer and interim CEO ("The Gray Sheet" Jan. 4, p. 17). In a March 1 release, the company said the changes "reflect the implementation of an effective management succession process and will further the development of a successful long-term strategic plan for the company." The firm also recently announced a reorganization of its senior management. Douglas Harrington, MD, was promoted to president of Nichols Institute Reference Laboratories, where he had been vice president of operations; Stephen Brase was promoted to president, Regional Laboratories, from the position of vice president, Western Regional Operations; and Nichols Institute Diagnostics President Frank Taylor, Jr. assumed the additional duties of executive vice president of Nichols Institute. Also announced was the termination of discussions for the sale of Nichols' Texas laboratories ("The Gray Sheet" Nov. 2, 1992, p. 17).

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000306

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel